Featured Image Alt Text	After uploading image → click → Edit alt text	Before and after schematic of periorbital area showing skin quality improvement from skin booster treatment in the under-eye zone

Best Skin Boosters for Under-Eye Rejuvenation: Clinical Review

Skin quality treatment of the periorbital area is one of the highest-value aesthetic services a practitioner can offer — patients who see genuine improvement in the appearance of tiredness and dark circles without the risks of tear trough filler are reliably among the most satisfied in any practice. But delivering that result requires a precise understanding of what the periorbital skin needs, what it cannot tolerate, and which product categories are clinically appropriate for this uniquely challenging zone.

Profhilo vs Korean Skin Boosters: A Clinical Product Comparison

Profhilo vs Korean Skin Boosters: A Clinical Product Comparison

Profhilo (IBSA, Italy) changed the UK skin booster market when it launched in 2015. Its innovative thermal hybridisation technology, high HA concentration, and elegantly simple 5-point injection protocol made it the reference product against which all subsequent biorevitalisation treatments have been measured. For many UK practitioners, Profhilo is the skin booster — the product they trained on, the one their patients know by name, and the one on which their protocols are built.

Cross-section skin diagram comparing skin booster intradermal microinjection on left versus dermal filler subcutaneous bolus placement on right showing depth difference

Skin Boosters: The Complete Practitioner's Guide to Biorevitalisation Injectables

Skin boosters have become one of the most searched and most requested injectable treatments in UK and European aesthetics — and one of the most misunderstood. The term is used loosely across the industry to describe a broad category of hydration-focused injectables that range from simple low-viscosity hyaluronic acid preparations to complex formulations combining HA with polynucleotides, amino acids, and growth factors. The clinical results, techniques, and patient selection criteria differ significantly across this spectrum.